<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
</head>
<body>
<p>Hi Marvin,</p>
<p>I don't understand the value of saying any of this:<br>
</p>
<p>
<blockquote type="cite">
<p style="line-height: 108%; margin-bottom: 0.11in"> <font
face="Times New Roman, serif"><font style="font-size: 12pt"
size="3">Licensor
does not have any obligation under this License to provide
any
protected health information (hereinafter referred to as </font></font><font
face="Times New Roman, serif"><font style="font-size: 12pt"
size="3"><b>“PHI”</b></font></font><font face="Times New
Roman, serif"><font style="font-size: 12pt" size="3">),
</font></font><font color="#242424"><font face="system-ui,
serif"><font style="font-size: 11pt" size="3"><span
style="background: #ffffff">as
defined in accordance with 45 CFR §160.103 </span></font></font></font><font
face="Times New Roman, serif"><font style="font-size: 12pt"
size="3">of
the Health Insurance Portability and Accountability Act
(HIPAA),</font></font><font face="Times New Roman, serif"><font
style="font-size: 12pt" size="3">
or other personal information, or to validate any data
generated by
the use of the Work. ..</font></font><font face="Times New
Roman, serif"><font style="font-size: 12pt" size="3">.
Licensor has attempted to </font></font><font face="Times
New Roman, serif"><font style="font-size: 12pt" size="3">delete
all copies of such personal information in the data, and
will
undertake to ensure that the Work does not contain any
data with
personal information. </font></font>
</p>
</blockquote>
What in the document, or in industry practice, suggests that you <i>would</i>
have an obligation to provide PII or validate data? Aren't you
just stating what would be true whether you say it or not?<br>
</p>
<p>And why would you promise to ensure that the Work does not
contain PII? I don't think that's a problem with whether the
license is open source, it just seems odd to me to undertake an
obligation, and potentially be liable for your failure, that you
have no duty to undertake.</p>
<p>Pam</p>
<div class="moz-signature">Pamela S. Chestek (in my personal
capacity)<br>
Chestek Legal<br>
PLEASE NOTE OUR NEW MAILING ADDRESS<br>
4641 Post St.<br>
Unit 4316<br>
El Dorado Hills, CA 95762<br>
+1 919-800-8033<br>
pamela@chesteklegal<br>
<a class="moz-txt-link-abbreviated" href="http://www.chesteklegal.com">www.chesteklegal.com</a><br>
<br>
<br>
</div>
<div class="moz-cite-prefix">On 3/4/2025 9:02 AM, Barksdale, Marvin
wrote:<br>
</div>
<blockquote type="cite"
cite="mid:BY5PR04MB6550FDD50E31B3725BD44F71CEC82@BY5PR04MB6550.namprd04.prod.outlook.com">
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta name="Generator" content="Microsoft Word 15 (filtered
medium)">
<style>@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}@font-face
{font-family:"Calibri Light";
panose-1:2 15 3 2 2 2 4 3 2 4;}@font-face
{font-family:Aptos;}p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Aptos",sans-serif;
mso-ligatures:standardcontextual;}p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
{mso-style-priority:99;
mso-style-link:"Plain Text Char";
margin:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;
mso-ligatures:standardcontextual;}p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
font-size:11.0pt;
font-family:"Aptos",sans-serif;
mso-ligatures:standardcontextual;}span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Aptos",sans-serif;
color:windowtext;}span.PlainTextChar
{mso-style-name:"Plain Text Char";
mso-style-priority:99;
mso-style-link:"Plain Text";
font-family:"Calibri",sans-serif;}.MsoChpDefault
{mso-style-type:export-only;
font-size:11.0pt;}div.WordSection1
{page:WordSection1;}ol
{margin-bottom:0in;}ul
{margin-bottom:0in;}</style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
<div class="WordSection1">
<p class="MsoPlainText">> Hi Marvin<o:p></o:p></p>
<p class="MsoPlainText">> I for one would be very grateful if
you would concisely highlight what you have changed here
please.<o:p></o:p></p>
<p class="MsoPlainText">> Thanks<o:p></o:p></p>
<p class="MsoPlainText">>Simon<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">No problem Simon and thanks for the assist
Mccoy. I’ll briefly summarize the significant changes to the
License and Proposal in text, as it was important for us to
put forth a clean proposal representing the most current
version of the document for review:<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoListParagraph"
style="text-indent:-.25in;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span
style="mso-list:Ignore">1.<span style="font:7.0pt
"Times New Roman"">
</span></span><!--[endif]-->Alignment of the License’s
grants: Expressly aligned the patent rights granted with the
license’s grant of rights , via one of Mccoy’s notes.
<o:p></o:p></p>
<p class="MsoListParagraph"
style="text-indent:-.25in;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span
style="mso-list:Ignore">2.<span style="font:7.0pt
"Times New Roman"">
</span></span><!--[endif]-->Clarification of
Anti-Proliferation critical license differences between Apache
2.0 and MGB 1.0<o:p></o:p></p>
<p class="MsoListParagraph"
style="margin-left:1.0in;text-indent:-.25in;mso-list:l0 level2
lfo1">
<!--[if !supportLists]--><span style="mso-list:Ignore">a.<span
style="font:7.0pt "Times New Roman"">
</span></span><!--[endif]-->MGB 1.0 Limits express the
Patent Grant to the licensed software itself eg. claims
embodied by the work
<o:p></o:p></p>
<p class="MsoListParagraph"
style="margin-left:1.0in;text-indent:-.25in;mso-list:l0 level2
lfo1">
<!--[if !supportLists]--><span style="mso-list:Ignore">b.<span
style="font:7.0pt "Times New Roman"">
</span></span><!--[endif]-->MGB 1.0 addresses (HIPAA)
guidelines pertaining to the work’s potential inclusion of
patient personal information<o:p></o:p></p>
<p class="MsoListParagraph"
style="text-indent:-.25in;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span
style="mso-list:Ignore">3.<span style="font:7.0pt
"Times New Roman"">
</span></span><!--[endif]-->Clarification that MGB 1.0’s
patent approach in narrowing the scope of the grant to the
software itself eg the use of “embodied” over “infringed”, is
similar to the patent grant mechanism utilized by the osi
approved AFL and the GNU v3 license, which narrows the claims
granted only to “essential patent claims,” not including
“claims that would be infringed only as a consequence of
further modification of the contributor version.” Similarly
these licenses intend to narrow their patent grants to claims
that are essential to open source distribution of the licensed
copyrighted IP, and not to claims that aren’t embodied by the
copyrighted IP or that would be infringed only as a
consequence of further modification of the contributor
version. Our chosen approach was akin to the AFL<o:p></o:p></p>
<p class="MsoListParagraph"
style="margin-left:1.0in;text-indent:-.25in;mso-list:l0 level2
lfo1">
<!--[if !supportLists]--><span style="mso-list:Ignore">a.<span
style="font:7.0pt "Times New Roman"">
</span></span><!--[endif]-->Note: The intent of MGB 1.0 is
not “contracting around DoE to reserve patent rights against
the code released under an open source license,” as patent
rights as preserved against the code released under the
license vs sperate code that was not. <o:p></o:p></p>
<p class="MsoListParagraph"
style="text-indent:-.25in;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span
style="mso-list:Ignore">4.<span style="font:7.0pt
"Times New Roman"">
</span></span><!--[endif]-->Simplified the Marketing
Derivative Works Authorship Notice of Section 5b to essential
notice reqs. <o:p></o:p></p>
<p class="MsoListParagraph"
style="text-indent:-.25in;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span
style="mso-list:Ignore">5.<span style="font:7.0pt
"Times New Roman"">
</span></span><!--[endif]-->Simplified the Section 6 HIPAA
acknowledgement to 3 terms:<o:p></o:p></p>
<p class="MsoListParagraph"
style="margin-left:1.0in;text-indent:-.25in;mso-list:l0 level2
lfo1">
<!--[if !supportLists]--><span style="mso-list:Ignore">a.<span
style="font:7.0pt "Times New Roman"">
</span></span><!--[endif]--> The Work may include Data,
which You may use<o:p></o:p></p>
<p class="MsoListParagraph"
style="margin-left:1.0in;text-indent:-.25in;mso-list:l0 level2
lfo1">
<!--[if !supportLists]--><span style="mso-list:Ignore">b.<span
style="font:7.0pt "Times New Roman"">
</span></span><!--[endif]-->However Author is not required
to verify Data or provide PHI and personal information
(according to HIPAA)<o:p></o:p></p>
<p class="MsoListParagraph"
style="margin-left:1.0in;text-indent:-.25in;mso-list:l0 level2
lfo1">
<!--[if !supportLists]--><span style="mso-list:Ignore">c.<span
style="font:7.0pt "Times New Roman"">
</span></span><!--[endif]-->Author will use best efforts to
remove personal information<o:p></o:p></p>
<p class="MsoListParagraph"
style="text-indent:-.25in;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span
style="mso-list:Ignore">6.<span style="font:7.0pt
"Times New Roman"">
</span></span><!--[endif]-->Maintained Sublicensing rights
while reducing implications and express terms of sublicensee
control.
<o:p></o:p></p>
<p class="MsoListParagraph"
style="text-indent:-.25in;mso-list:l0 level1 lfo1"><!--[if !supportLists]--><span
style="mso-list:Ignore">7.<span style="font:7.0pt
"Times New Roman"">
</span></span><!--[endif]-->Simplified Limitation of
Liability Section 10 to essential terms<o:p></o:p></p>
<p class="MsoListParagraph"
style="margin-left:1.0in;text-indent:-.25in;mso-list:l0 level2
lfo1">
<!--[if !supportLists]--><span style="mso-list:Ignore">a.<span
style="font:7.0pt "Times New Roman"">
</span></span><!--[endif]-->In no event will Licensor /
Contributor / Staff be liable to You / Contributor
<o:p></o:p></p>
<p class="MsoListParagraph"
style="margin-left:1.0in;text-indent:-.25in;mso-list:l0 level2
lfo1">
<!--[if !supportLists]--><span style="mso-list:Ignore">b.<span
style="font:7.0pt "Times New Roman"">
</span></span><!--[endif]-->Explicit Explanation of Limit to
the liability.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Happy to provide any clarification and
needed and thanks for reviewing the full text of both docs.
<o:p></o:p></p>
<p class="MsoNormal"><b><span style="font-family:"Calibri
Light",sans-serif;color:#009CA6;mso-ligatures:none">__________________</span></b><span
style="mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><span
style="font-size:16.0pt;font-family:"Calibri
Light",sans-serif;color:black;mso-ligatures:none">Marvin
Barksdale</span><span
style="font-family:"Calibri",sans-serif;mso-ligatures:none"><o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
<p class="MsoNormal">The information in this e-mail is intended
only for the person to whom it is addressed. If you believe
this e-mail was sent to you in error and the e-mail contains
patient information, please contact the Mass General Brigham
Compliance HelpLine at <a
href="https://www.massgeneralbrigham.org/complianceline"
moz-do-not-send="true" class="moz-txt-link-freetext">https://www.massgeneralbrigham.org/complianceline</a>
.</p>
<br>
<p class="MsoNormal">Please note that this e-mail is not secure
(encrypted). If you do not wish to continue communication over
unencrypted e-mail, please notify the sender of this message
immediately. Continuing to send or respond to e-mail after
receiving this message means you
understand and accept this risk and wish to continue to
communicate over
unencrypted e-mail. </p>
<br>
<fieldset class="moz-mime-attachment-header"></fieldset>
<pre class="moz-quote-pre" wrap="">_______________________________________________
The opinions expressed in this email are those of the sender and not necessarily those of the Open Source Initiative. Communication from the Open Source Initiative will be sent from an opensource.org email address.
License-review mailing list
<a class="moz-txt-link-abbreviated" href="mailto:License-review@lists.opensource.org">License-review@lists.opensource.org</a>
<a class="moz-txt-link-freetext" href="http://lists.opensource.org/mailman/listinfo/license-review_lists.opensource.org">http://lists.opensource.org/mailman/listinfo/license-review_lists.opensource.org</a>
</pre>
</blockquote>
</body>
</html>